RA
FLGT icon

Royce & Associates’s Fulgent Genetics FLGT Stock Holding History

Royce & Associates’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-26,851
Closed -$718K – 895
2023
Q3 		$718K Sell
26,851
-12,266
-31% -$419K 0.01% 775
2023
Q2 		$1.45M Sell
39,117
-6,432
-14% -$224K 0.01% 706
2023
Q1 		$1.42M Buy
45,549
+19,791
+77% +$637K 0.01% 723
2022
Q4 		$767K Sell
25,758
-27,772
-52% -$994K 0.01% 788
2022
Q3 		$2.04M Sell
53,530
-6,593
-11% -$331K 0.02% 624
2022
Q2 		$3.28M Sell
60,123
-4,884
-8% -$268K 0.03% 578
2022
Q1 		$4.06M Buy
65,007
+55,212
+564% +$3.64M 0.03% 599
2021
Q4 		$985K Buy
9,795
+4,878
+99% +$429K 0.01% 808
2021
Q3 		$442K Buy
+4,917
New +$447K ﹤0.01% 914
2020
Q1 		– Sell
-48,209
Closed -$622K – 1164
2019
Q4 		$622K Hold
48,209
– – 0.01% 863
2019
Q3 		$501K Sell
48,209
-3,464
-7% -$32.9K ﹤0.01% 901
2019
Q2 		$345K Buy
51,673
+14,612
+39% +$89K ﹤0.01% 943
2019
Q1 		$221K Hold
37,061
– – ﹤0.01% 994
2018
Q4 		$117K Sell
37,061
-35,350
-49% -$124K ﹤0.01% 997
2018
Q3 		$285K Hold
72,411
– – ﹤0.01% 999
2018
Q2 		$300K Buy
72,411
+4,500
+7% +$17.8K ﹤0.01% 1037
2018
Q1 		$270K Buy
67,911
+17,900
+36% +$78.8K ﹤0.01% 1077
2017
Q4 		$219K Buy
+50,011
New +$192K ﹤0.01% 1084

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royce & Associates's FLGT Position: Q4 2023 in Review

Royce & Associates sold out of Fulgent Genetics (FLGT) in Q4 2023, closing a stake of 26,851 shares — an estimated $718K sold.

Royce & Associates first reported a position in FLGT in Q4 2017 and held it in 18 quarters. The position peaked at $4.06M in Q1 2022. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2023.

  • Royce & Associates reported no remaining Fulgent Genetics position as of Q4 2023 after selling out during the quarter.
  • Royce & Associates sold 26,851 Fulgent Genetics shares in Q4 2023, an estimated $718K.
  • Royce & Associates first reported a position in Fulgent Genetics in Q4 2017 and held it in 18 quarters.
  • Royce & Associates's Fulgent Genetics position peaked at $4.06M in Q1 2022.
  • 196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2023.

Based on Royce & Associates's 13F filing for Q4 2023, filed 12 Feb 2024.